APA (7th ed.) Citation

Hara, T., Yamagami, H., Uemoto, R., Sekine, A., Kaneko, Y., Miyataka, K., . . . Aihara, K. (2025). Pemafibrate Ameliorates Steatotic Liver Disease Regardless of Endothelial Dysfunction in Mice. Antioxidants, 14(7), 891. https://doi.org/10.3390/antiox14070891

Chicago Style (17th ed.) Citation

Hara, Tomoyo, et al. "Pemafibrate Ameliorates Steatotic Liver Disease Regardless of Endothelial Dysfunction in Mice." Antioxidants 14, no. 7 (2025): 891. https://doi.org/10.3390/antiox14070891.

MLA (9th ed.) Citation

Hara, Tomoyo, et al. "Pemafibrate Ameliorates Steatotic Liver Disease Regardless of Endothelial Dysfunction in Mice." Antioxidants, vol. 14, no. 7, 2025, p. 891, https://doi.org/10.3390/antiox14070891.